AUS
NZ
UK
CA
USA
IND
Healthcare
Why Healthcare Stocks Like Pro Medicus (ASX:PME) And CSL (ASX:CSL) Are Bouncing Back
July 01, 2026 01:40 PM AEST| By SamHealthcare stocks rebounded strongly as Pro Medicus, CSL, Ramsay Health Care and Sonic Healthcare recovered, while Echo IQ, Biome Australia and Memphasys delivered notable corporate developments supporting sector momentum.
Amcor (ASX:AMC) or Sonic Healthcare (ASX:SHL): Which ASX Share Looks More Compelling Right Now?
July 01, 2026 11:22 AM AEST| By SamAmcor and Sonic Healthcare continue attracting attention through global operations, diversified revenue streams and resilient business models as packaging innovation and healthcare demand remain long-term structural growth themes.
Kalina Power (ASX:KPO), Mitchell Services (ASX:MSV) and Sigma Healthcare (ASX:SIG): Why These ASX Stocks Are Gaining Attention
July 01, 2026 11:03 AM AEST| By SamKalina Power, Mitchell Services and Sigma Healthcare remain under market attention through improving financial resilience, disciplined balance sheet management and continued operational progress across Australia's energy, mining and healthcare sector...
Siren Gold (ASX: SNG) Rises 20% as High-Grade Gold Exploration Continues to Build Momentum
July 01, 2026 03:12 AM AEST| By Aditi Sarkar• Siren Gold shares climbed 20.00% to AUD 0.054 during Wednesday's trading session.
Why Is 4DMedical (ASX:4DX) Leading the ASX 200 FY26 Winners?
July 01, 2026 09:48 AM AEST| By SamAustralia's latest financial year highlighted contrasting sector performance, with mining supporting the broader market while 4DMedical gained attention through regulatory progress, commercial expansion and healthcare technology innovation.
CSL (ASX:CSL) Shares Back in Focus as Healthcare Giant Rebuilds
June 30, 2026 10:47 PM AEST| By SamCSL is regaining attention as its resilient plasma franchise, steady underlying earnings and ongoing restructuring reinforce the company's position as one of Australia's leading healthcare businesses despite near-term operational challenges.
Why Are CSL (ASX:CSL) Shares Rallying as Healthcare Roars Back?
June 30, 2026 10:20 PM AEST| By Vivek SinghCSL led Australia's healthcare rebound as capital shifted away from resource companies into defensive growth businesses, placing renewed attention on restructuring progress and the sector's improving market sentiment.
Clinical Trial Progress Sparks Fresh Interest in Imugene (ASX: IMU) Shares
July 01, 2026 03:11 AM AEST| By Aditi Sarkar• Imugene shares surged 21.74% to AUD 0.14 during Wednesday's trading session.
Why Pro Medicus (ASX:PME) Is Back in Focus After a Landmark US Deal
June 30, 2026 10:19 PM AEST| By Vivek SinghPro Medicus strengthened its position in healthcare technology after expanding a major US contract, reinforcing the success of its Visage Seven platform and highlighting continued momentum across large American healthcare networks.
Why Is Pro Medicus (ASX:PME) Testing Healthcare Stocks?
June 30, 2026 03:31 PM AEST| By SamASX healthcare stocks are facing a clinical validation test as regulatory progress, specialist technology and rare-disease updates place execution quality back in focus.
Why Is CSL (ASX:CSL) Central to Healthcare Rebound?
June 30, 2026 03:31 PM AEST| By SamASX healthcare stocks are being tested through quality rebound, with earnings confidence, clinical credibility and margin discipline shaping the latest market screen.
Is Megaport (ASX:MP1) Showing Investor Interest Despite Lower Volume?
June 30, 2026 01:16 PM AEST| By Sonal Goyal• Shares rise 6.357% to 21.580 with strong upward session movement.
Why Is Pro Medicus (ASX:PME) Driving the Diagnostics Shift in ASX Healthcare Stocks?
June 30, 2026 03:31 PM AEST| By SamAustralia's healthcare sector is increasingly defined by diagnostics, medical imaging and workflow technology, with leading healthcare companies demonstrating how innovation and commercial execution continue reshaping industry attention.
Epiminder (ASX:EPI): Cash Position Remains Under Market Spotlight
June 30, 2026 10:08 AM AEST| By SamEpiminder continues advancing its healthcare technology platform while maintaining financial flexibility, with cash management, product development and commercial execution remaining central to its long-term growth strategy.
CSL (ASX:CSL): Are AI Imaging Deals Changing Healthcare Valuations?
June 29, 2026 04:41 PM AEST| By SamASX healthcare stocks are being assessed through AI imaging partnerships, commercial channels, clinical progress and defensive earnings as medical technology becomes a sharper valuation signal.
Can Increased Volume Signal Changing Momentum for Neuren Pharmaceuticals (ASX:NEU) stock?
June 30, 2026 01:15 PM AEST| By Sonal Goyal• Shares rise 6.927% to 17.750, with volume above average levels.
Biotech Stocks: The Milestone Map Investors Are Reading Into July
June 29, 2026 04:40 PM AEST| By SamAustralia's healthcare sector is focusing on biotechnology milestones, commercial execution, medical technology adoption and defensive earnings as investors assess operational progress before the new financial year.
Why Is ResMed (ASX:RMD) Winning Back the ASX 200 Healthcare Story?
June 29, 2026 04:03 PM AEST| By SamResMed's latest quarterly performance highlighted stronger revenue growth and improving profitability, helping refocus attention on operational execution and the long-term demand for sleep healthcare solutions.
Why Is CSL (ASX:CSL) Facing Its Toughest Healthcare Test in Years?
June 29, 2026 04:02 PM AEST| By SamCSL has returned to focus as Australia's healthcare sector experiences broad weakness driven by changing market sentiment, sector rotation and renewed attention on defensive industries.
Is Electro Optic (ASX:EOS) Approaching Upper Range Resistance After Recent Gains?
June 30, 2026 01:15 PM AEST| By Sonal Goyal• Shares rise 6.625% to 10.300 with active intraday trading.
Why Is Cochlear (ASX:COH) Facing Its Biggest Challenge Yet?
June 29, 2026 04:02 PM AEST| By SamCochlear has reset earnings expectations following weaker procedure volumes and hospital constraints, while its long-term healthcare business continues to benefit from structural demand for hearing solutions.
Neuren Pharmaceuticals (ASX:NEU) Draws Attention as Drug Pipeline Strengthens
June 29, 2026 10:06 AM AEST| By SamNeuren Pharmaceuticals continues advancing its rare disease pipeline as clinical development, licensing partnerships and regulatory progress remain key long-term business drivers.
Why Is Telix Pharmaceuticals (ASX:TLX) Standing Out This Year?
June 28, 2026 07:19 PM AEST| By SamTelix Pharmaceuticals, Lindian Resources and GemLife Communities showcase Australia's diverse growth landscape through healthcare innovation, rare earth development and specialised residential community expansion.
Is IperionX (ASX:IPX) Showing Recovery Signs Within Its 52-Week Range?
June 30, 2026 01:15 PM AEST| By Sonal Goyal• Shares rise 5.974% to 4.080 with steady intraday price movement.
Why Is 4DMedical (ASX:4DX) Back in the Healthcare Spotlight?
June 28, 2026 04:03 PM AEST| By Sam4DMedical continues advancing its respiratory imaging technology through commercial expansion, healthcare innovation and growing clinical adoption across Australia and the United States.
Why ResMed (ASX:RMD) Is Rebuilding Confidence on the ASX 200?
June 26, 2026 07:57 PM AEST| By SamResMed continues demonstrating resilient healthcare demand through respiratory devices, digital health platforms and recurring revenue as market attention returns to its operating fundamentals.
Advertise your brand on Kalkine Media